Vistagen Therapeutics, Inc. (VTGN)
4.54
+0.25
(+5.83%)
USD |
NASDAQ |
Dec 09, 16:00
4.55
+0.01
(+0.22%)
After-Hours: 17:32
Vistagen Therapeutics EPS Diluted (Quarterly): -0.5432 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| XOMA Royalty Corp. | 0.6991 |
| Omeros Corp. | -0.4666 |
| GeoVax Labs, Inc. | -0.3115 |
| Daré Bioscience, Inc. | -0.2793 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.42M |
| Revenue (Quarterly) | 0.258M |
| Total Expenses (Quarterly) | 19.68M |
| Enterprise Value | 94.13M |
| Gross Profit Margin (Quarterly) | 28.29% |
| Profit Margin (Quarterly) | -7.53K% |
| Earnings Yield | -41.80% |
| Normalized Earnings Yield | -41.80 |